Skip to content

Clinical efficacy evaluation of Jingxin Zhidong recipe in the treatment of children with tic disorder and its correlation with allergic indexes

Clinical efficacy evaluation of Jingxin Zhidong recipe in the treatment of children with tic disorder and its correlation with allergic indexes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048422
Enrollment
Unknown
Registered
2021-07-06
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tic Disorder (TD)

Interventions

Sponsors

Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. TD group inclusion criteria: (1) Outpatients attending the Department of Pediatrics, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences; (2) Meet the diagnostic criteria of TD western medicine and traditional Chinese medicine, and aged 6-16 years; (3) Patients with no history of chorea, athetosis, autism, hepatolenticular degeneration, childhood schizophrenia, epilepsy, drug-induced, tardive dyskinesia, hysteria or acute dyskinesia; (4) Those who have not suffered from autoimmune diseases or rheumatic diseases in the past three months; (5) The patient has not taken immune enhancement or inhibitor, allergic transmitter blocker or antagonistic drugs in the past year. 2 Inclusion criteria for the healthy group: (1) Children undergoing physical examination at Guang'anmen Hospital of China Academy of Chinese Medical Sciences; (2) Aged between 6 and 16 years; (3) No history of exogenous disease in the past two weeks; (4) No immune enhancement or inhibitor, allergic transmitter blocker or antagonist drug has been taken in the past year.

Exclusion criteria

Exclusion criteria: 1. TD group exclusion criteria: (1) Those who refuse to sign the informed consent; (2) Abnormal maternal pregnancy and birth history; (3) The main indicators of liver and kidney function and urine routine test report are abnormal; (4) Those who cannot accept oral Chinese medicine; (5) Those who participate in other clinical trials at the same time. 2. Exclusion criteria for healthy group: (1) Those who refuse to sign the informed consent; (2) Abnormal maternal pregnancy and birth history; (3) Those with abnormal main indicators returned by physical examination of liver and kidney function and urine routine test.

Design outcomes

Primary

MeasureTime frame
Yale comprehensive tic severity scale;

Secondary

MeasureTime frame
ISAAC scale;

Countries

China

Contacts

Public ContactHan Fei

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

hanfei@gamyy.cn+86 13693134383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026